|
Safety and Efficacy of MK-8669 (Ridaforolimus) + MK-2206 (AKT Inhibitor) in Patients with Advanced Breast Cancer with PI3K Pathway Dependence |
|
|
|
Title: |
Safety and Efficacy of MK-8669 (Ridaforolimus) + MK-2206 (AKT Inhibitor) in Patients with Advanced Breast Cancer with PI3K Pathway Dependence |
Author: |
Gupta, S. Munster, P. Hollebecque, A. Argiles, G. Guren, T. Cheng, J. Wang, R. Swift, A. Tosolini, A. Piha-Paul, S. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 25 () nr. S1 pages i25 |
Year: |
2014 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|